Nationwide Fund Advisors - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 69 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$22,000
-12.0%
27,6120.0%0.00%
Q4 2016$25,000
+25.0%
27,6120.0%0.00%
Q3 2016$20,000
-44.4%
27,6120.0%0.00%
Q2 2016$36,000
-84.0%
27,612
-7.6%
0.00%
-100.0%
Q1 2015$225,000
+102.7%
29,886
-7.7%
0.00%
Q4 2014$111,000
-0.9%
32,365
+1.6%
0.00%
Q3 2014$112,000
-57.4%
31,865
+1.0%
0.00%
-100.0%
Q2 2014$263,000
+56.5%
31,542
+19.6%
0.00%0.0%
Q1 2014$168,000
-1.2%
26,383
+10.7%
0.00%0.0%
Q4 2013$170,000
+3.0%
23,834
+8.1%
0.00%0.0%
Q3 2013$165,000
+39.8%
22,042
+7.6%
0.00%0.0%
Q2 2013$118,00020,4940.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders